Hy2Care
Latest round
- Series A
Last raised
- Apr 2019
Total raised
- $4.1M
Investors
- 2
About Hy2Care
V.V. is dedicated to creating advanced medical treatments for cartilage defects. Founded in 2014, the company is based in the Netherlands.Hy2Care® specializes in the development and commercialization of the CartRevive® hydrogel implant, designed to facilitate the functional recovery of cartilage defects in joints. This innovative implant utilizes natural polymers that mimic joint tissue, providing a protective environment for injured areas and promoting natural healing. The CartRevive® implant primarily targets patients suffering from cartilage damage, thereby filling a vital need in the healthcare market.Hy2Care® generates revenue through direct sales of its CartRevive® hydrogel implant to healthcare providers, including hospitals and orthopedic clinics. The company engages in B2B transactions, forming partnerships with medical institutions for clinical applications.V. The company aims to introduce new product designs and launch initiatives targeting specific market expansions, particularly into the United States, enhancing its offerings for orthopedic professionals.
Who invested in Hy2Care
2 investors across 1 round
See all investors in Hy2Care
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 30, 2019
Amount
$4.1M
Investors
Questions about Hy2Care
Who invested in Hy2Care?
Hy2Care has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hy2Care raised?
Hy2Care has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Hy2Care last raise money?
Hy2Care's most recent round on record is a Series A, in Apr 2019.
What does Hy2Care do?
Hy2Care is a pharmaceuticals company.
Where is Hy2Care headquartered?
Hy2Care is headquartered in Netherlands.
Which VCs invest in companies like Hy2Care?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at Hy2Care's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Hy2Care? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.